Investors and executives are optimistic these investments will pay off not just for venture capitalists, but for cancer patients.
Mike Reddy for STAT In the fight against cancer, it's boom times for radiopharmaceuticals The radiopharmaceutical world is now approaching critical mass. There are currently around 75 such startups in the U.S., several of which have raised sizable financing rounds this year. But to achieve anything, radiopharmaceutical companies must hurriedly address supply and production challenges — issues that have handicapped other promising areas of oncology drug development. Read more. By Allison DeAngelis |
|
Scott Olson/Getty Images How pharmacy deserts are putting the health of Black and Latino Americans at risk As pharmacies shutter stores across the U.S., people in low-income and predominantly Black, Latino, and Indigenous neighborhoods are increasingly left in pharmacy deserts, without easy access to medications and other essentials. Read more. By Anika Nayak Daniel Slim/AFP via Getty Images Exclusive: Cancun abortion clinic aims to serve Americans from restrictive states More than 5.6 million U.S. tourists head to Cancun every year. Soon there's likely to be another reason to visit: MSI Reproductive Choices, an international reproductive health nonprofit, plans to open an abortion clinic in the city, partly designed to cater to travelers from the U.S. who are unable to get an abortion in their home states. Read more. By Olivia Goldhill More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments